July 30, 2018 10:32 AM EDT

Redhill spikes — briefly — on positive Crohn's data; Daiichi inks global licensing deal with Glycotope

John Carroll

Editor & Founder

→ Shares of Israel’s Redhill BioPharma $RDHL spiked Monday morning — then quickly began to slide back — after the biotech laid out data demonstrating how …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Redhill spikes — briefly — on positive Crohn's data; Daiichi inks global licensing deal with Glycotope

John Carroll

Editor & Founder

Sign up to read this article for free.

Updated: CEO of UnitedHealth insurance unit shot and killed in New York in what police call ‘a brazen, targeted ...

Lilly beats Novo in bellwether head-to-head weight loss study

As 23andMe struggles, another genetic testing company bets on drug discovery

Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model

Lilly drops body mass ranges from FDA label for weight loss drug

GSK makes another ADC deal, this time with BioNTech's partner DualityBio

Red­hill spikes — briefly — on pos­i­tive Crohn's da­ta; Dai­ichi inks glob­al li­cens­ing deal with Gly­co­tope

John Carroll

Editor & Founder

Sign up to read this article for free.

more like this

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Redhill spikes — briefly — on positive Crohn's data; Daiichi inks global licensing deal with Glycotope

Updated: CEO of UnitedHealth insurance unit shot and killed in New York in what police call ‘a brazen, targeted ...

Lilly beats Novo in bellwether head-to-head weight loss study

As 23andMe struggles, another genetic testing company bets on drug discovery

Bluebird and Vertex's sickle cell gene therapies to kick off new Medicaid access model

Lilly drops body mass ranges from FDA label for weight loss drug

GSK makes another ADC deal, this time with BioNTech's partner DualityBio